We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetic Studies Designed to Diagnose and Treat Complex Diseases

By Biotechdaily staff writers
Posted on 09 May 2007
A genome-wide human single nucleotide polymorphisms (SNP) array 5.0 has been chosen to genotype more than 17,000 individuals.

The German National Genome Research Network (NGFN, Bonn, Germany) has selected Affymetrix (Santa Clara, CA, USA) technology to help researchers better understand the underlying causes and develop more effective treatments for 25 complex diseases, including Alzheimer's, epilepsy, heart diseases, malaria, and Parkinson's. More...
The NGFN will use the new SNP array 6.0 when it becomes available later this year.

With this large-scale project, we hope to encourage the launch of further projects of this kind, said Prof. Stefan Schreiber of the University of Kiel (Germany). Our aim is to discover how similar diseases are linked in order to identify genes related to multiple diseases. In near time, the global community will have the chance of a joint analysis across countries using multiple association samples. The ability to analyze large sample cohorts such as these with cutting-edge technologies is crucial to understanding complex genetics.

The latest NGFN project builds on the success of the first project, which focused on developing a control cohort database that would be free and available to the public. The database is enabling researchers from both academia and the pharmaceutical industry to reduce the number of required control samples and increase the genetic power of their current studies by adding age- and sex-matched controls from similar ethnic backgrounds as their cases. As a result of this project and others around the world, the Affymetrix Control Program is now the world's largest population genetics resource, containing genotype data from more than 12,000 samples.

The project is part of one of the world's largest genetic research efforts. The NGFN consists of a team of scientists from more than 10 research institutions around the country who are committed to standardizing the set of controls, protocols, and analysis tools for whole-genome association studies. Results of the studies will flow into a database accessible to both researchers from academia and the pharmaceutical industry.

The Affymetrix SNP array 5.0 was developed to help researchers better identify and understand the genetic variations associated with complex diseases, such as autism, bipolar disease, cancer, diabetes, and heart disease. The SNP array 5.0 features from the original Affymetrix two-chip 500K array set, as well as 420,000 additional probes that can measure other genetic differences, such as copy number variation. The SNP array 5.0 gives researchers a significant increase in information above the original 500K array set for the same price, while reducing the array processing time. The NGFN will also have access to the next-generation SNP array 6.0, which is expected to be available later this year.


Related Links:
Affymetrix
University of Kiel

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automatic CLIA Analyzer
Shine i6000
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.